Clinical Trial Update: T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for T-cells expressing anti-CD19 CAR in pediatric and young adult patients with B-cell malignancies across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia Precursor
• Non-hodgkin Lymphoma

Drugs mentioned

• CAR-γδT cells targeting CD19 (CAR-γδT cell therapy encoding anti-CD19 specificity)

Snippet

Sponsor: Sheba Medical Center | Conditions: Acute Lymphoblastic Leukemia, B-precursor, Non-Hodgkin Lymphoma, B-cell | Phase 1, Phase 2 | Status: UNKNOWN